Table 1.
Demographic and baseline characteristics.
| Characteristic | All (n = 31) |
|---|---|
| Age (years), mean (SD) | 52.35 (9.714) |
| Female sex, n (%) | 18 (58) |
| Male sex, n (%) | 13 (42) |
| Body Mass Index, mean (SD) | 26.68 (5.237) |
| Diagnosis of asthma, years, median (IQR) | 15 (10–23) |
| Blood eosinophils, mean (range) median (SEM) |
1219 (293–7180) 791 (273.8) |
| FEV1 (l), mean (SD) | 2.15 (0.81) |
| OCS therapy dependent, n (%) | 21 (67.7) |
| OCS mg/30days, median (IQR) | 56.25 (0 -112-.5) |
| Number of exacerbations/year, median (IQR) | 6 (4–12) |
| Smoking status, n (%) | |
| Active smoker | 3 (10) |
| Ex-smoker | 7 (22) |
| Non-smoker | 21 (68) |
| Comorbid conditions prevalence, n (%) | |
| Nasal polyps | 24 (77.4) |
| GERD | 10 (32.2) |
| NARES | 12 (38.7) |
| Obesity | 11 (35.5) |
| Allergy | 22 (71) |
| Bronchiectasis | 17 (54.8) |
SD, standard deviation; IQR, interquartile range; SEM, standard error mean; GERD, Gastro-esophageal reflux disease; NARES, Nonallergic rhinitis with eosinophilia syndrome